Volume 11, Number 10—October 2005
Dispatch
Drug-resistant Escherichia coli, Rural Idaho
Elizabeth L. Hannah*
, Frederick J. Angulo†, James R. Johnson‡§, Bassam Haddadin*, Jacquelyn Williamson*, and Matthew H. Samore*¶
, Frederick J. Angulo†, James R. Johnson‡§, Bassam Haddadin*, Jacquelyn Williamson*, and Matthew H. Samore*¶
Table 3
Healthcare/antimicrobial use in 517 study participants collected from questionnaires and pharmacy data*
| Characteristic | No. (%) |
|---|---|
| Ambulatory visit in past 6 mo | 266 (52) |
| Diabetic | 13 (3) |
| Antimicrobial use in past month | 37 (7) |
| No. outpatient visits (past 6 mo) | |
| 0 | 251 (49) |
| 1 | 125 (49) |
| 2 | 59 (23) |
| 3 | 29 (11) |
| 4 | 14 (5) |
| >5 | 32 (12) |
| No. hospitalizations (past 6 mo) | |
| 0 | 483 (93) |
| 1 | 31 (6) |
| 2 | 2 (0) |
| 3 | 1 (0) |
| No. courses of antimicrobial agents in the past year | |
| 0 | 333 (64) |
| 1 | 91 (18) |
| 2 | 39 (8) |
| 3 | 19 (4) |
| 4 | 16 (3) |
| >5 | 19 (4) |
| Antimicrobial classes, no. with >1 course | |
| TMP/SMZ | |
| Past month | 2 (0.4) |
| Past year | 10 (2) |
| Fluoroquinolones | |
| Past month | 7 (1) |
| Past year | 17 (3) |
| Cephalosporins | |
| Past month | 4 (1) |
| Past year | 37 (7) |
| Penicillin | |
| Past month | 18 (4) |
| Past year | 107 (21) |
| Macrolide | |
| Past month | 3 (1) |
| Past year | 24 (5) |
*TMP/SMZ, trimethoprim/sulfamethoxazole.
Page created: February 22, 2012
Page updated: February 22, 2012
Page reviewed: February 22, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.